BP
DNLI icon

Ballentine Partners’s Denali Therapeutics DNLI Stock Holding History

Ballentine Partners’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-25,000
Closed -$544K – 343
2018
Q3 		$544K Buy
+25,000
New +$544K 0.03% 185